Kartik Chandran - Publications

Affiliations: 
2001 University of Wisconsin, Madison, Madison, WI 

73 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Dieterle ME, Solà-Riera C, Ye C, Goodfellow SM, Mittler E, Kasikci E, Bradfute SB, Klingström J, Jangra RK, Chandran K. Genetic depletion studies inform receptor usage by virulent hantaviruses in human endothelial cells. Elife. 10. PMID 34232859 DOI: 10.7554/eLife.69708  0.36
2021 Li T, Li Z, Deans EE, Mittler E, Liu M, Chandran K, Ivanovic T. The shape of pleomorphic virions determines resistance to cell-entry pressure. Nature Microbiology. PMID 33737748 DOI: 10.1038/s41564-021-00877-0  0.72
2021 Fels JM, Bortz RH, Alkutkar T, Mittler E, Jangra RK, Spence JS, Chandran K. A Glycoprotein Mutation That Emerged during the 2013-2016 Ebola Virus Epidemic Alters Proteolysis and Accelerates Membrane Fusion. Mbio. 12. PMID 33593971 DOI: 10.1128/mBio.03616-20  0.36
2021 Mittler E, Alkutkar T, Jangra RK, Chandran K. Direct Intracellular Visualization of Ebola Virus-Receptor Interaction by Proximity Ligation. Mbio. 12. PMID 33436438 DOI: 10.1128/mBio.03100-20  0.36
2020 Bortz RH, Wong AC, Grodus MG, Recht HS, Pulanco MC, Lasso G, Anthony SJ, Mittler E, Jangra RK, Chandran K. A virion-based assay for glycoprotein thermostability reveals key determinants of filovirus entry and its inhibition. Journal of Virology. PMID 32611759 DOI: 10.1128/JVI.00336-20  0.36
2020 Jia M, Liberatore RA, Guo Y, Chan KW, Pan R, Lu H, Waltari E, Mittler E, Chandran K, Finzi A, Kaufmann DE, Seaman MS, Ho DD, Shapiro L, Sheng Z, et al. VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA. Cell Host & Microbe. PMID 32315598 DOI: 10.1016/J.Chom.2020.03.024  0.36
2019 Mittler E, Dieterle ME, Kleinfelter LM, Slough MM, Chandran K, Jangra RK. Hantavirus entry: Perspectives and recent advances. Advances in Virus Research. 104: 185-224. PMID 31439149 DOI: 10.1016/Bs.Aivir.2019.07.002  0.36
2018 Jangra RK, Herbert AS, Li R, Jae LT, Kleinfelter LM, Slough MM, Barker SL, Guardado-Calvo P, Román-Sosa G, Dieterle ME, Kuehne AI, Muena NA, Wirchnianski AS, Nyakatura EK, Fels JM, ... Chandran K, et al. Protocadherin-1 is essential for cell entry by New World hantaviruses. Nature. 563: 559-563. PMID 30464266 DOI: 10.1038/S41586-018-0702-1  0.36
2017 Hofmann D, Zak SE, Nyakatura EK, Mittler E, Bakken RR, Chandran K, Dye JM, Lai JR. Mechanistic and Fc Requirements for Inhibition of Sudan Virus Entry and In Vivo Protection by a Synthetic Antibody. Immunology Letters. PMID 28890093 DOI: 10.1016/J.Imlet.2017.09.002  0.36
2016 Wec AZ, Nyakatura EK, Herbert AS, Howell KA, Holtsberg FW, Bakken RR, Mittler E, Christin JR, Shulenin S, Jangra RK, Bharrhan S, Kuehne AI, Bornholdt ZA, Flyak AI, Saphire EO, ... ... Chandran K, et al. A "Trojan horse" bispecific antibody strategy for broad protection against ebolaviruses. Science (New York, N.Y.). PMID 27608667 DOI: 10.1126/Science.Aag3267  0.96
2016 van der Linden WA, Schulze CJ, Herbert AS, Krause TB, Wirchnianski AA, Dye JM, Chandran K, Bogyo M. Cysteine Cathepsin Inhibitors as Anti-Ebola Agents. Acs Infectious Diseases. 2: 173-179. PMID 27347558 DOI: 10.1021/Acsinfecdis.5B00130  0.96
2016 Afonso CL, Amarasinghe GK, Bányai K, Bào Y, Basler CF, Bavari S, Bejerman N, Blasdell KR, Briand FX, Briese T, Bukreyev A, Calisher CH, Chandran K, Chéng J, Clawson AN, et al. Taxonomy of the order Mononegavirales: update 2016. Archives of Virology. PMID 27216929 DOI: 10.1007/S00705-016-2880-1  0.96
2016 Howell KA, Qiu X, Brannan JM, Bryan C, Davidson E, Holtsberg FW, Wec AZ, Shulenin S, Biggins JE, Douglas R, Enterlein SG, Turner HL, Pallesen J, Murin CD, He S, ... ... Chandran K, et al. Antibody Treatment of Ebola and Sudan Virus Infection via a Uniquely Exposed Epitope within the Glycoprotein Receptor-Binding Site. Cell Reports. PMID 27160900 DOI: 10.1016/J.Celrep.2016.04.026  0.96
2016 Spence JS, Krause TB, Mittler E, Jangra RK, Chandran K. Direct Visualization of Ebola Virus Fusion Triggering in the Endocytic Pathway. Mbio. 7. PMID 26861015 DOI: 10.1128/Mbio.01857-15  0.96
2016 Frei JC, Nyakatura EK, Zak SE, Bakken RR, Chandran K, Dye JM, Lai JR. Bispecific Antibody Affords Complete Post-Exposure Protection of Mice from Both Ebola (Zaire) and Sudan Viruses. Scientific Reports. 6: 19193. PMID 26758505 DOI: 10.1038/Srep19193  0.96
2015 Bornholdt ZA, Ndungo E, Fusco ML, Bale S, Flyak AI, Crowe JE, Chandran K, Saphire EO. Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies. Mbio. 7. PMID 26908579 DOI: 10.1128/Mbio.02154-15  0.96
2015 Ng M, Ndungo E, Kaczmarek ME, Herbert AS, Binger T, Kuehne AI, Jangra RK, Hawkins JA, Gifford RJ, Biswas R, Demogines A, James RM, Yu M, Brummelkamp TR, Drosten C, ... ... Chandran K, et al. Filovirus receptor NPC1 contributes to species-specific patterns of ebolavirus susceptibility in bats. Elife. 4. PMID 26698106 DOI: 10.7554/Elife.11785  0.96
2015 Basu A, Mills DM, Mitchell D, Ndungo E, Williams JD, Herbert AS, Dye JM, Moir DT, Chandran K, Patterson JL, Rong L, Bowlin TL. Novel Small Molecule Entry Inhibitors of Ebola Virus. The Journal of Infectious Diseases. 212: S425-34. PMID 26206510 DOI: 10.1093/Infdis/Jiv223  0.96
2015 Kleinfelter LM, Jangra RK, Jae LT, Herbert AS, Mittler E, Stiles KM, Wirchnianski AS, Kielian M, Brummelkamp TR, Dye JM, Chandran K. Haploid Genetic Screen Reveals a Profound and Direct Dependence on Cholesterol for Hantavirus Membrane Fusion. Mbio. 6. PMID 26126854 DOI: 10.1128/Mbio.00801-15  0.96
2015 Herbert AS, Davidson C, Kuehne AI, Bakken R, Braigen SZ, Gunn KE, Whelan SP, Brummelkamp TR, Twenhafel NA, Chandran K, Walkley SU, Dye JM. Niemann-pick C1 is essential for ebolavirus replication and pathogenesis in vivo. Mbio. 6: e00565-15. PMID 26015498 DOI: 10.1128/Mbio.00565-15  0.96
2015 Brojatsch J, Lima H, Palliser D, Jacobson LS, Muehlbauer SM, Furtado R, Goldman DL, Lisanti MP, Chandran K. Distinct cathepsins control necrotic cell death mediated by pyroptosis inducers and lysosome-destabilizing agents. Cell Cycle (Georgetown, Tex.). 14: 964-72. PMID 25830414 DOI: 10.4161/15384101.2014.991194  0.96
2014 Ng M, Ndungo E, Jangra RK, Cai Y, Postnikova E, Radoshitzky SR, Dye JM, Ramírez de Arellano E, Negredo A, Palacios G, Kuhn JH, Chandran K. Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1. Virology. 468: 637-46. PMID 25310500 DOI: 10.1016/J.Virol.2014.08.019  0.96
2014 Kuhn JH, Andersen KG, Bào Y, Bavari S, Becker S, Bennett RS, Bergman NH, Blinkova O, Bradfute S, Brister JR, Bukreyev A, Chandran K, Chepurnov AA, Davey RA, Dietzgen RG, et al. Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names. Viruses. 6: 3663-82. PMID 25256396 DOI: 10.3390/V6093663  0.96
2014 Chen G, Koellhoffer JF, Zak SE, Frei JC, Liu N, Long H, Ye W, Nagar K, Pan G, Chandran K, Dye JM, Sidhu SS, Lai JR. Synthetic antibodies with a human framework that protect mice from lethal Sudan ebolavirus challenge. Acs Chemical Biology. 9: 2263-73. PMID 25140871 DOI: 10.1021/Cb5006454  0.96
2014 Brojatsch J, Lima H, Kar AK, Jacobson LS, Muehlbauer SM, Chandran K, Diaz-Griffero F. A proteolytic cascade controls lysosome rupture and necrotic cell death mediated by lysosome-destabilizing adjuvants. Plos One. 9: e95032. PMID 24893007 DOI: 10.1371/Journal.Pone.0095032  0.96
2014 Lennemann NJ, Rhein BA, Ndungo E, Chandran K, Qiu X, Maury W. Comprehensive functional analysis of N-linked glycans on Ebola virus GP1. Mbio. 5: e00862-13. PMID 24473128 DOI: 10.1128/Mbio.00862-13  0.96
2014 Koellhoffer JF, Dai Z, Malashkevich VN, Stenglein MD, Liu Y, Toro R, S Harrison J, Chandran K, DeRisi JL, Almo SC, Lai JR. Structural characterization of the glycoprotein GP2 core domain from the CAS virus, a novel arenavirus-like species. Journal of Molecular Biology. 426: 1452-68. PMID 24333483 DOI: 10.1016/J.Jmb.2013.12.009  0.96
2014 Kuhn JH, Bào Y, Bavari S, Becker S, Bradfute S, Brauburger K, Rodney Brister J, Bukreyev AA, Caì Y, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Gonzalez JP, et al. Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA. Archives of Virology. 159: 1229-37. PMID 24190508 DOI: 10.1007/S00705-013-1877-2  0.96
2014 Bukreyev AA, Chandran K, Dolnik O, Dye JM, Ebihara H, Leroy EM, Mühlberger E, Netesov SV, Patterson JL, Paweska JT, Saphire EO, Smither SJ, Takada A, Towner JS, Volchkov VE, et al. Discussions and decisions of the 2012–2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012–June 2013. Archives of Virology. 159: 821-30. PMID 24122154 DOI: 10.1007/S00705-013-1846-9  0.96
2013 Higgins CD, Koellhoffer JF, Chandran K, Lai JR. C-peptide inhibitors of Ebola virus glycoprotein-mediated cell entry: effects of conjugation to cholesterol and side chain-side chain crosslinking. Bioorganic & Medicinal Chemistry Letters. 23: 5356-60. PMID 23962564 DOI: 10.1016/J.Bmcl.2013.07.056  0.96
2013 Lima H, Jacobson LS, Goldberg MF, Chandran K, Diaz-Griffero F, Lisanti MP, Brojatsch J. Role of lysosome rupture in controlling Nlrp3 signaling and necrotic cell death. Cell Cycle (Georgetown, Tex.). 12: 1868-78. PMID 23708522 DOI: 10.4161/Cc.24903  0.96
2013 Regula LK, Harris R, Wang F, Higgins CD, Koellhoffer JF, Zhao Y, Chandran K, Gao J, Girvin ME, Lai JR. Conformational properties of peptides corresponding to the ebolavirus GP2 membrane-proximal external region in the presence of micelle-forming surfactants and lipids. Biochemistry. 52: 3393-404. PMID 23650881 DOI: 10.1021/Bi400040V  0.96
2013 Kuhn JH, Bao Y, Bavari S, Becker S, Bradfute S, Brister JR, Bukreyev AA, Caì Y, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Gonzalez JP, Formenty P, et al. Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae. Archives of Virology. 158: 1425-32. PMID 23358612 DOI: 10.1007/S00705-012-1594-2  0.96
2013 Martinez O, Ndungo E, Tantral L, Miller EH, Leung LW, Chandran K, Basler CF. A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner. Journal of Virology. 87: 3324-34. PMID 23302883 DOI: 10.1128/Jvi.01598-12  0.96
2013 Jacobson LS, Lima H, Goldberg MF, Gocheva V, Tsiperson V, Sutterwala FS, Joyce JA, Gapp BV, Blomen VA, Chandran K, Brummelkamp TR, Diaz-Griffero F, Brojatsch J. Cathepsin-mediated necrosis controls the adaptive immune response by Th2 (T helper type 2)-associated adjuvants. The Journal of Biological Chemistry. 288: 7481-91. PMID 23297415 DOI: 10.1074/Jbc.M112.400655  0.96
2013 Kuhn JH, Bao Y, Bavari S, Becker S, Bradfute S, Brister JR, Bukreyev AA, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Hensley LE, Honko AN, Jahrling PB, et al. Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Archives of Virology. 158: 301-11. PMID 23001720 DOI: 10.1007/S00705-012-1454-0  0.96
2012 Bhattacharyya S, Mulherkar N, Chandran K. Endocytic pathways involved in filovirus entry: advances, implications and future directions. Viruses. 4: 3647-64. PMID 23342373 DOI: 10.3390/V4123647  0.96
2012 Krishnan A, Miller EH, Herbert AS, Ng M, Ndungo E, Whelan SP, Dye JM, Chandran K. Niemann-Pick C1 (NPC1)/NPC1-like1 chimeras define sequences critical for NPC1's function as a flovirus entry receptor. Viruses. 4: 2471-84. PMID 23202491 DOI: 10.3390/V4112471  0.96
2012 Koellhoffer JF, Chen G, Sandesara RG, Bale S, Saphire EO, Chandran K, Sidhu SS, Lai JR. Two synthetic antibodies that recognize and neutralize distinct proteolytic forms of the ebola virus envelope glycoprotein. Chembiochem : a European Journal of Chemical Biology. 13: 2549-57. PMID 23111988 DOI: 10.1002/Cbic.201200493  0.96
2012 Koellhoffer JF, Malashkevich VN, Harrison JS, Toro R, Bhosle RC, Chandran K, Almo SC, Lai JR. Crystal structure of the Marburg virus GP2 core domain in its postfusion conformation. Biochemistry. 51: 7665-75. PMID 22935026 DOI: 10.1021/Bi300976M  0.96
2012 Bale S, Dias JM, Fusco ML, Hashiguchi T, Wong AC, Liu T, Keuhne AI, Li S, Woods VL, Chandran K, Dye JM, Saphire EO. Structural basis for differential neutralization of ebolaviruses. Viruses. 4: 447-70. PMID 22590681 DOI: 10.3390/V4040447  0.96
2012 Miller EH, Chandran K. Filovirus entry into cells - new insights. Current Opinion in Virology. 2: 206-14. PMID 22445965 DOI: 10.1016/J.Coviro.2012.02.015  0.96
2012 Miller EH, Obernosterer G, Raaben M, Herbert AS, Deffieu MS, Krishnan A, Ndungo E, Sandesara RG, Carette JE, Kuehne AI, Ruthel G, Pfeffer SR, Dye JM, Whelan SP, Brummelkamp TR, ... Chandran K, et al. Ebola virus entry requires the host-programmed recognition of an intracellular receptor. The Embo Journal. 31: 1947-60. PMID 22395071 DOI: 10.1038/Emboj.2012.53  0.96
2012 Harrison JS, Koellhoffer JF, Chandran K, Lai JR. Marburg virus glycoprotein GP2: pH-dependent stability of the ectodomain α-helical bundle. Biochemistry. 51: 2515-25. PMID 22369502 DOI: 10.1021/Bi3000353  0.96
2012 Misasi J, Chandran K, Yang JY, Considine B, Filone CM, Côté M, Sullivan N, Fabozzi G, Hensley L, Cunningham J. Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences. Journal of Virology. 86: 3284-92. PMID 22238307 DOI: 10.1128/Jvi.06346-11  0.96
2011 Dias JM, Kuehne AI, Abelson DM, Bale S, Wong AC, Halfmann P, Muhammad MA, Fusco ML, Zak SE, Kang E, Kawaoka Y, Chandran K, Dye JM, Saphire EO. A shared structural solution for neutralizing ebolaviruses. Nature Structural & Molecular Biology. 18: 1424-7. PMID 22101933 DOI: 10.1038/Nsmb.2150  0.96
2011 Martinez O, Tantral L, Mulherkar N, Chandran K, Basler CF. Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles. The Journal of Infectious Diseases. 204: S825-32. PMID 21987758 DOI: 10.1093/Infdis/Jir295  0.96
2011 Mulherkar N, Raaben M, de la Torre JC, Whelan SP, Chandran K. The Ebola virus glycoprotein mediates entry via a non-classical dynamin-dependent macropinocytic pathway. Virology. 419: 72-83. PMID 21907381 DOI: 10.1016/J.Virol.2011.08.009  0.96
2011 Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, Mulherkar N, Kuehne AI, Kranzusch PJ, Griffin AM, Ruthel G, Dal Cin P, Dye JM, Whelan SP, Chandran K, Brummelkamp TR. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature. 477: 340-3. PMID 21866103 DOI: 10.1038/Nature10348  0.96
2011 Côté M, Misasi J, Ren T, Bruchez A, Lee K, Filone CM, Hensley L, Li Q, Ory D, Chandran K, Cunningham J. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature. 477: 344-8. PMID 21866101 DOI: 10.1038/Nature10380  0.96
2011 Harrison JS, Higgins CD, Chandran K, Lai JR. Designed protein mimics of the Ebola virus glycoprotein GP2 α-helical bundle: stability and pH effects. Protein Science : a Publication of the Protein Society. 20: 1587-96. PMID 21739501 DOI: 10.1002/Pro.688  0.96
2011 Miller EH, Harrison JS, Radoshitzky SR, Higgins CD, Chi X, Dong L, Kuhn JH, Bavari S, Lai JR, Chandran K. Inhibition of Ebola virus entry by a C-peptide targeted to endosomes. The Journal of Biological Chemistry. 286: 15854-61. PMID 21454542 DOI: 10.1074/Jbc.M110.207084  0.96
2010 Wong AC, Sandesara RG, Mulherkar N, Whelan SP, Chandran K. A forward genetic strategy reveals destabilizing mutations in the Ebolavirus glycoprotein that alter its protease dependence during cell entry. Journal of Virology. 84: 163-75. PMID 19846533 DOI: 10.1128/Jvi.01832-09  0.96
2008 Ivanovic T, Agosto MA, Zhang L, Chandran K, Harrison SC, Nibert ML. Peptides released from reovirus outer capsid form membrane pores that recruit virus particles. The Embo Journal. 27: 1289-98. PMID 18369316 DOI: 10.1038/Emboj.2008.60  0.96
2007 Ivanovic T, Agosto MA, Chandran K, Nibert ML. A role for molecular chaperone Hsc70 in reovirus outer capsid disassembly. The Journal of Biological Chemistry. 282: 12210-9. PMID 17284448 DOI: 10.1074/Jbc.M610258200  0.96
2006 Zhang L, Chandran K, Nibert ML, Harrison SC. Reovirus mu1 structural rearrangements that mediate membrane penetration. Journal of Virology. 80: 12367-76. PMID 17005655 DOI: 10.1128/Jvi.01343-06  0.96
2006 Coffey CM, Sheh A, Kim IS, Chandran K, Nibert ML, Parker JS. Reovirus outer capsid protein micro1 induces apoptosis and associates with lipid droplets, endoplasmic reticulum, and mitochondria. Journal of Virology. 80: 8422-38. PMID 16912293 DOI: 10.1128/Jvi.02601-05  0.96
2005 Chandran K, Sullivan NJ, Felbor U, Whelan SP, Cunningham JM. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science (New York, N.Y.). 308: 1643-5. PMID 15831716 DOI: 10.1126/Science.1110656  0.96
2005 Nibert ML, Odegard AL, Agosto MA, Chandran K, Schiff LA. Putative autocleavage of reovirus mu1 protein in concert with outer-capsid disassembly and activation for membrane permeabilization. Journal of Molecular Biology. 345: 461-74. PMID 15581891 DOI: 10.1016/J.Jmb.2004.10.026  0.96
2004 Ehrlich M, Boll W, Van Oijen A, Hariharan R, Chandran K, Nibert ML, Kirchhausen T. Endocytosis by random initiation and stabilization of clathrin-coated pits. Cell. 118: 591-605. PMID 15339664 DOI: 10.1016/J.Cell.2004.08.017  0.96
2004 Odegard AL, Chandran K, Zhang X, Parker JS, Baker TS, Nibert ML. Putative autocleavage of outer capsid protein micro1, allowing release of myristoylated peptide micro1N during particle uncoating, is critical for cell entry by reovirus. Journal of Virology. 78: 8732-45. PMID 15280481 DOI: 10.1128/Jvi.78.16.8732-8745.2004  0.96
2004 Hutchings AB, Helander A, Silvey KJ, Chandran K, Lucas WT, Nibert ML, Neutra MR. Secretory immunoglobulin A antibodies against the sigma1 outer capsid protein of reovirus type 1 Lang prevent infection of mouse Peyer's patches. Journal of Virology. 78: 947-57. PMID 14694126 DOI: 10.1128/Jvi.78.2.947-957.2004  0.96
2003 Chandran K, Parker JS, Ehrlich M, Kirchhausen T, Nibert ML. The delta region of outer-capsid protein micro 1 undergoes conformational change and release from reovirus particles during cell entry. Journal of Virology. 77: 13361-75. PMID 14645591 DOI: 10.1128/Jvi.77.24.13361-13375.2003  0.96
2003 Chandran K, Nibert ML. Animal cell invasion by a large nonenveloped virus: reovirus delivers the goods. Trends in Microbiology. 11: 374-82. PMID 12915095 DOI: 10.1016/S0966-842X(03)00178-1  0.96
2003 Helander A, Silvey KJ, Mantis NJ, Hutchings AB, Chandran K, Lucas WT, Nibert ML, Neutra MR. The viral sigma1 protein and glycoconjugates containing alpha2-3-linked sialic acid are involved in type 1 reovirus adherence to M cell apical surfaces. Journal of Virology. 77: 7964-77. PMID 12829836 DOI: 10.1128/Jvi.77.14.7964-7977.2003  0.96
2003 Odegard AL, Chandran K, Liemann S, Harrison SC, Nibert ML. Disulfide bonding among micro 1 trimers in mammalian reovirus outer capsid: a late and reversible step in virion morphogenesis. Journal of Virology. 77: 5389-400. PMID 12692241 DOI: 10.1128/Jvi.77.9.5389-5400.2003  0.96
2002 Chandran K, Farsetta DL, Nibert ML. Strategy for nonenveloped virus entry: a hydrophobic conformer of the reovirus membrane penetration protein micro 1 mediates membrane disruption. Journal of Virology. 76: 9920-33. PMID 12208969 DOI: 10.1128/Jvi.76.19.9920-9933.2002  0.96
2002 Liemann S, Chandran K, Baker TS, Nibert ML, Harrison SC. Structure of the reovirus membrane-penetration protein, Mu1, in a complex with is protector protein, Sigma3. Cell. 108: 283-95. PMID 11832217 DOI: 10.1016/S0092-8674(02)00612-8  0.96
2002 Middleton JK, Severson TF, Chandran K, Gillian AL, Yin J, Nibert ML. Thermostability of reovirus disassembly intermediates (ISVPs) correlates with genetic, biochemical, and thermodynamic properties of major surface protein mu1. Journal of Virology. 76: 1051-61. PMID 11773381 DOI: 10.1128/Jvi.76.3.1051-1061.2002  0.96
2001 Chandran K, Zhang X, Olson NH, Walker SB, Chappell JD, Dermody TS, Baker TS, Nibert ML. Complete in vitro assembly of the reovirus outer capsid produces highly infectious particles suitable for genetic studies of the receptor-binding protein. Journal of Virology. 75: 5335-42. PMID 11333914 DOI: 10.1128/Jvi.75.11.5335-5342.2001  0.96
2000 Farsetta DL, Chandran K, Nibert ML. Transcriptional activities of reovirus RNA polymerase in recoated cores Journal of Biological Chemistry. 275: 39693-39701. PMID 11007773 DOI: 10.1074/Jbc.M004562200  0.96
1999 Chandran K, Walker SB, Chen Y, Contreras CM, Schiff LA, Baker TS, Nibert ML. In vitro recoating of reovirus cores with baculovirus-expressed outer-capsid proteins mu1 and sigma3. Journal of Virology. 73: 3941-50. PMID 10196289 DOI: 10.1128/Jvi.73.5.3941-3950.1999  0.96
1998 Chandran K, Nibert ML. Protease cleavage of reovirus capsid protein μ1/μ1C is blocked by alkyl sulfate detergents, yielding a new type of infectious subvirion particle Journal of Virology. 72: 467-475. PMID 9420247 DOI: 10.1128/Jvi.72.1.467-475.1998  0.96
Show low-probability matches.